Table 4

Habila: point estimates, 95% CIs, and width of CIs (in ppt) for child-level indicators, by sampling design

Indicator
Sampling design


33 × 6 design
67 × 3 design
30 × 30 design

GAM
4.7 (1.9, 7.4) +/- 2.8
8.0 (4.5, 11.5) +/- 3.5
6.9 (4.8, 9.0) +/- 2.1
Low MUAC (<12.5 cm)
4.0 (0.7, 7.4) +/- 3.4
3.0 (0.7, 5.3) +/- 2.3
3.3 (2.0, 4.7) +/- 1.4
Stunting
26.0 (19.1, 32.8) +/- 6.9
25.4 (19.4, 31.4) +/- 6.0
27.3 (23.8, 30.9) +/- 3.6
Underweight
22.9 (16.8, 29.1) +/- 6.2
27.6 (21.1, 34.1) +/- 6.5
27.4 (24.0, 30.9) +/- 3.5
BCG vaccination
26.8 (16.4, 37.1) +/- 10.4
40.3 (31.6, 49.0) +/- 8.7
35.2 (28.0, 42.5) +/- 7.3
Measles vaccination
57.4 (43.7, 71.1) +/- 13.7
55.0 (45.0, 65.0) +/- 10.0
55.4 (45.3, 65.5) +/- 10.1
VAC supplementation (5.5 month recall)
74.1 (61.7, 86.6) +/- 12.5
69.7 (59.7, 79.6) +/- 10.0
77.7 (67.1, 88.4) +/- 10.7
Diarrhea (2 week recall)
6.6 (2.2, 11.0) +/- 4.4
6.0 (2.3, 9.7) +/- 3.7
10.9 (6.6, 15.2) +/- 4.3
ARI (2 week recall)
6.1 (1.9, 10.2) +/- 4.2
6.0 (2.0, 10.0) +/- 4.0
3.4 (1.9, 5.0) +/- 1.6
Fever (2 week recall)
16.2 (9.8, 22.5) +/- 6.4
21.6 (15.3, 28.0) +/- 6.4
18.4 (14.5, 22.2) +/- 3.9

Deitchler et al. Emerging Themes in Epidemiology 2008 5:6   doi:10.1186/1742-7622-5-6